Review
The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes
Giuseppe Banfi et al. Clin Chem Lab Med. 2007.
Abstract
Anticoagulants are used to prevent clot formation both in vitro and in vivo. In the specific field of in vitro diagnostics, anticoagulants are commonly added to collection tubes either to maintain blood in the fluid state for hematological testing or to obtain suitable plasma for coagulation and clinical chemistry analyses. Unfortunately, no universal anticoagulant that could be used for evaluation of several laboratory parameters in a sample from a single test tube is available so far. Ethylenediamine tetraacetic acid (EDTA) is a polyprotic acid containing four carboxylic acid groups and two amine groups with lone-pair electrons that chelate calcium and several other metal ions. Calcium is necessary for a wide range of enzyme reactions of the coagulation cascade and its removal irreversibly prevents blood clotting within the collection tube. Historically, EDTA has been recommended as the anticoagulant of choice for hematological testing because it allows the best preservation of cellular components and morphology of blood cells. The remarkable expansion in laboratory test volume and complexity over recent decades has amplified the potential spectrum of applications for this anticoagulant, which can be used to stabilize blood for a variety of traditional and innovative tests. Specific data on the behavior of EDTA as an anticoagulant in hematology, including possible pitfalls, are presented. The use of EDTA for measuring cytokines, protein and peptides, and cardiac markers is described, with an outline of the protection of labile molecules provided by this anticoagulant. The use of EDTA in proteomics and in general clinical chemistry is also described in comparison with other anticoagulants and with serum samples. Finally, the possible uses of alternative anticoagulants instead of EDTA and the potential use of a universal anticoagulant are illustrated.
Similar articles
The use of hirudin as universal anticoagulant in haematology, clinical chemistry and blood grouping.
Menssen HD, Melber K, Brandt N, Thiel E. Menssen HD, et al. Clin Chem Lab Med. 2001 Dec;39(12):1267-77. doi: 10.1515/CCLM.2001.204. Clin Chem Lab Med. 2001. PMID: 11798089
A practical and novel method to extract genomic DNA from blood collection kits for plasma protein preservation.
Waters J, Dhere V, Benjamin A, Sekar A, Kumar A, Prahalad S, Okou DT, Kugathasan S. Waters J, et al. J Vis Exp. 2013 May 18;(75):e4241. doi: 10.3791/4241. J Vis Exp. 2013. PMID: 23711730 Free PMC article.
UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant.
Barri T, Dragsted LO. Barri T, et al. Anal Chim Acta. 2013 Mar 20;768:118-28. doi: 10.1016/j.aca.2013.01.015. Epub 2013 Jan 18. Anal Chim Acta. 2013. PMID: 23473258
Clot activators and anticoagulant additives for blood collection. A critical review on behalf of COLABIOCLI WG-PRE-LATAM.
Lima-Oliveira G, Brennan-Bourdon LM, Varela B, Arredondo ME, Aranda E, Flores S, Ochoa P. Lima-Oliveira G, et al. Crit Rev Clin Lab Sci. 2021 May;58(3):207-224. doi: 10.1080/10408363.2020.1849008. Epub 2020 Dec 2. Crit Rev Clin Lab Sci. 2021. PMID: 33929278 Review.
Cited by
An unusual case of sodium citrate-dependent artifactual platelet count.
Dima F, Salvagno GL, Danese E, Veneri D, Lippi G. Dima F, et al. Interv Med Appl Sci. 2019 Oct 7;11(3):193-196. doi: 10.1556/1646.11.2019.24. eCollection 2020 Sep. Interv Med Appl Sci. 2019. PMID: 36343287 Free PMC article.
Head-to-Head Comparison of Different Blood Collecting Tubes for Quantification of Alzheimer's Disease Biomarkers in Plasma.
Jiang L, Ding X, Wang W, Yang X, Li T, Lei P. Jiang L, et al. Biomolecules. 2022 Aug 28;12(9):1194. doi: 10.3390/biom12091194. Biomolecules. 2022. PMID: 36139033 Free PMC article.
Control of Line Complications with KiteLock (CLiCK) in the critical care unit: study protocol for a multi-center, cluster-randomized, double-blinded, crossover trial investigating the effect of a novel locking fluid on central line complications in the critical care population.
Ornowska M, Wong H, Ouyang Y, Mitra A, White A, Willems S, Wittmann J, Reynolds S. Ornowska M, et al. Trials. 2022 Aug 30;23(1):719. doi: 10.1186/s13063-022-06671-5. Trials. 2022. PMID: 36042488 Free PMC article.
The peripheral blood mononuclear cells preparation and the hematology of Varanus salvator.
Thanasak J, Tansatit T, Taowan J, Hirunwiroj N, Chitthichanonte S, Wongmack T. Thanasak J, et al. PLoS One. 2022 Jul 22;17(7):e0269108. doi: 10.1371/journal.pone.0269108. eCollection 2022. PLoS One. 2022. PMID: 35867719 Free PMC article.
From the Free Ligand to the Transition Metal Complex: FeEDTA- Formation Seen at Ligand K-Edges.
Eckert S, Mascarenhas EJ, Mitzner R, Jay RM, Pietzsch A, Fondell M, Vaz da Cruz V, Föhlisch A. Eckert S, et al. Inorg Chem. 2022 Jul 11;61(27):10321-10328. doi: 10.1021/acs.inorgchem.2c00789. Epub 2022 Jun 28. Inorg Chem. 2022. PMID: 35764301 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
- De Gruyter
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information